| THURSDAY, MARCH 6, 2008 |
| 15:00 – 16:30 |
SSNN SATELLITE SYMPOSIUM |
| 16:30 – 17:00 |
Coffee Break |
| 17:00 – 18:30 |
PLENARY SESSION I - GLOBAL IMPACT OF TOTAL RISK |
Hall A |
| 17:00 |
BMI, SBP, CHOLESTEROL AND 55 000 VASCULAR DEATHS AMONG ONE MILLION ADULTS:
PROSPECTIVE STUDIES COLLABORATION (PSC)
G. Whitlock, UK |
| 17:20 |
CARDIOVASCULAR RISK SCORE: HOW TO ASSESS AND IMPLEMENT SCORE IN GENERAL
PRACTICE
S. Ebrahim, UK |
| 17:40 |
STROKE PREVENTION IN WOMEN
J. Pitha, Czech Republic |
| 18:00 |
MULTIFACTORIAL INTERVENTION AND TREATMENT ADHERENCE IN VASCULAR DISEASE
O. Pedersen, Denmark |
| 18:20 |
DISCUSSION |
| 18:30 – 19:00 |
OPENING CEREMONY |
Hall A |
| 18:30 |
INTRODUCTION
N.M. Bornstein, Israel
P. Amarenco, France
P. Kalvach, Czech Republic |
| |
PRAGUE BLACK THEARTRE SHOW
Followed by Get Together Reception |
|
|
|
| FRIDAY, MARCH 7, 2008 |
| 08:30 – 10:00 |
PLENARY SESSION II: HYPERTENSION |
Hall A |
| 08:30 |
CENTRAL VS. PERIPHERAL BLOOD PRESSURE: WHAT DID WE LEARN FROM ASCOT-CAFÉ?
P. Lacy, UK |
| 08:50 |
BENEFIT OF LOWERING BOTH BLOOD PRESSURE AND LIPID
P. Sever, UK |
| 09:10 |
HYPERTENSION AND PREVENTION OF STROKE: WHEN TO START WHAT DRUG AND HOW LOW
CAN WE GO?
J.J. Mourad, France |
| 09:30 |
BRAIN MICROBLEEDS IN PATIENTS WITH HYPERTENSION: A MARKER OF HYPERTENSIVE
ORGAN DAMAGE AND A PREDICTOR OF STROKE?
L.H.G. Henskens, The Netherlands |
| 09:50 |
DISCUSSION |
| 10:00 |
Coffee Break, Exhibition and Poster Viewing (Poster Session I) |
| 10:30 - 12:00 |
PLENARY III - METABOLIC SYNDROME |
Hall A |
| 10:30 |
METABOLIC SYNDROME IN THE POPULATION: OVERVIEW
G. Mancia, Italy |
| 10:45 |
TREATMENT OF METABOLIC SYNDROME AND HIGH NORMAL BLOOD PRESSURE.
EUROPEAN GUIDELINES
G. Mancia, Italy |
| 11:00 |
METABOLIC SYNDROME AND ETHNICITY
R.S. Bhopal, UK |
| 11:15 |
ENERGY STORAGE IN ANIMAL KINGDOM: COMMONALITIES WITH HUMAN METABOLIC
SYNDROME
M.P. Hermans, Belgium, |
| 11:30 |
ENDOCANABINOID RECEPTOR BLOCKERS
R. Carmena, Spain Tbc |
| 11:50 |
DISCUSSION |
| 12:00 |
Lunch Break, Exhibition and Poster Viewing |
| 14:00 - 15:50 |
PLENARY SESSION IV - DIABETES |
Hall A |
| 14:00 |
DIABETES AND VASCULAR COGNITIVE DECLINE
M. Brainin, Austria |
| 14:20 |
BIOMARKERS, DIABETES AND CARDIOVASCULAR DISEASE: DO BIOMARKERS ADD ANYTHING?
P. Durrington, UK |
| 14:40 |
NEW ONSET DIABETES AND HYPERTENSION: BENIGN OR MALIGNANT
P. Sever, UK |
| 15:00 |
DO DIABETES CONTROL REDUCE STROKE AND OTHER VASCULAR EVENTS?
J. Tuomilehto, Finland |
| 15:20 – 15:50 |
KEYNOTE LECTURE |
Hall A |
| |
RISK MODIFICATION TO REDUCE THE GLOBAL BURDEN OF STROKE
P. Sandercock, UK |
| 15:50 |
Coffee Break Exhibition and Poster Viewing |
| 16:20 – 17:50 |
FREE COMMUNICATION I: |
| 16:20 – 18:00 |
FREE COMMUNICATION II: |
| |
|
| SATURDAY, MARCH 8, 2008 |
| 08:00 – 09:00 |
FREE COMMUNICATION III: |
Hall B |
| 09:00 - 10:40 |
PLENARY V - ARTERIAL WALL MOTION AND RISK |
Hall A |
| 09:00 |
VASCULAR EFFECTS AND THE INTERACTION OF CARDIOVASCULAR RISK FACTORS
J. Halcox, UK |
| 09:20 |
ARTERIAL STIFFNESS: EARLY MARKERS OF SUBCLINICAL ORGAN DAMAGE IN DIABETES AND
PRE DIABETES
D. Russell, Norway |
| 09:40 |
ANTIHYPERTENSIVE THERAPY AND SYSTOLIC BLOOD PRESSURE REDUCTION
M. Safar, France |
| 10:00 |
VASOMOTOR REACTIVITY AND RISK FACTORS
L. Csiba, Hungary |
| 10:20 |
VASOMOTOR REACTIVITY AND DRUG INTERVENTION
H.S. Markus, UK |
| 10:40 |
Coffee Break, Exhibition and Poster Viewing (Poster Session II) |
| 11:10 - 12:50 |
PLENARY VI - CAROTID IMT IN VASCULAR DISEASE |
Hall A |
| 11:10 |
CAROTID IMT, PLAQUE AND STENOSIS: DEFINITION AND QUANTIFICATION.THE MANNHEIM
CONSENSUS
N.M. Bornstein, Israel |
| 11:30 |
VASCULAR RISK ASSESSMENT: WHICH ADDED VALUE FROM CAROTID IMT EVALUATION?
P-J. Touboul, France |
| 11:50 |
DRUG INTERVENTION ON CAROTID IMT PROGRESSION: CONTRIBUTION OF META-ANALYSES
M. Sitzer, Germany |
| 12:10 |
MODULATING PROGRESSION OF ADVANCED ATHEROSCLEROSIS IN THE CAROTIDS AND
VASCULAR RISK BY FLUVASTATIN AND FENOFIBRATE — NUS STUDY
D. Školoudík, Czech Republic |
| 12:30 |
EFFECT OF CEA AND STENTING ON CAROTID HAEMODYNAMICS
P. Kalvach, Czech Republic |
| 12:50 |
Lunch Break, Exhibition and Poster Viewing (Poster Session II) |
| 14:00 – 15:40 |
PLENARY VII – LIPIDS |
Hall A |
| 14:00 |
INTRODUCTION
D. Harats, Israel |
| 14:10 |
HDL-CHOLESTEROL AND STROKE RISK
D. Tanne, Israel |
| 14:30 |
TREATMENT OF STROKE: WHAT PERSPECTIVE FOR PPAR-α AGONISTS AND ACAT INHIBITORS?
R. Bordet, France |
| 14:50 |
DO STATINS REDUCE STROKE RISK?
H. Sillesen, Denmark |
| 15:10 |
HOW STATINS REDUCE STROKE RISK?
P. Amarenco, France |
| 15:30 |
CLOSING REMARKS |
